|
Unilever Throws in the Towel on GSK Business Buy After Rejection22 Jan 2022
After a rejection from GlaxoSmithKline on a proposed $68 billion buyout of its consumer healthcare business, Unilever is all but... Continue Reading
|
|
Theta Dermatology of Altamont, New York Joins Schweiger Dermatology Group22 Jan 2022
Schweiger Dermatology Group, the leading dermatology practice in the Northeast, has announced the acquisition of Theta Dermatology in Altamont, New... Continue Reading
|
|
BioAdaptives Signs Letter of Intent to Acquire Oxygenated Water Technology Patent22 Jan 2022
BioAdaptives, Inc. (OTCMkts: BDPT) announced today that it has entered into a Letter of Intent with inventor Thomas J. Mohr,... Continue Reading
|
|
Probo Medical Acquires REMETRONIX22 Jan 2022
Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair, and service, today announced the completion of... Continue Reading
|
|
UCB Doubles Down on Rare Diseases with $1.9B Zogenix Deal22 Jan 2022
Belgian pharmaceutical company UCB has announced that it is acquiring U.S. biopharma Zogenix as part of plans to expand its... Continue Reading
|
|
Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC22 Jan 2022
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the acquisition of Project Beacon COVID-19 LLC... Continue Reading
|
|
Lyra Health Acquires ICAS World to Expand Its Mental Health Care Services Globally22 Jan 2022
Lyra Health, the leading provider of innovative Workforce Mental Health solutions for employers, today announced it has acquired ICAS World,... Continue Reading
|
|
Bruker Acquires Prolab Instruments to Augment Multiomics Solutions22 Jan 2022
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Prolab Instruments GmbH, a Swiss technology company specialized in low-flow, high... Continue Reading
|
|
Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings22 Jan 2022
Eluminex Biosciences (Suzhou) Limited (Eluminex), an ophthalmology-focused biotechnology company headquartered in Suzhou, China with a US-subsidiary office in the San... Continue Reading
|
|
Smith+Nephew Acquires Novel Cementless Partial Knee System22 Jan 2022
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the acquisition of Engage Surgical, owner of the only... Continue Reading
|